As expected, we saw higher cytotoxic activity when peptide-loaded and reference target splenocyte populations (Figure 3E) or antigen-negative and antigen-positive tumor cells were injected into host mice that received PTPN2-deficient OT-I cells (Figure 3F). Here, PTPN2 is linked to neoplasm.